Outlook Therapeutics Insider Faisal Ghiath Buys 122,174 Shares Amid FDA Win and Market Surge【News Flash】
Insider buying surges at Outlook Therapeutics as FDA win fuels investor confidence in the eye‑treatment pipeline, boosting stock momentum.
3 minutes to read